LongCovid
A new perspective article published by Frontiers in Medicine proposes a multipronged clinical trial platform approach that addresses the complexity and heterogeneity of Post-COVID and ME/CFS, enabling to test numerous drugs in clinical trials in a harmonized manner accompanied by comprehensive mechanistic studies.
Frontiers | Fighting Post-COVID and ME/CFS – development of curative therapies (frontiersin.org)
EuCARE answers to an emergency call from the European Union, in the frame of the Horizon Europe programme, to confront the COVID-19 epidemics and in particular the newly emerging…
Very interesting position paper led by Dr. Amy Proal reviewing studies that have identified SARS-CoV-2 RNA/protein or immune responses indicative of a SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC) samples. „SARS-CoV-2 reservoir may drive inflammatory,…
Do not miss this very interesting article published by The Intelligencer (New York Magazine) about Lisa Sanders, internal-medicine doctor at Yale University School of Medicine, and her job at…
Don’t miss the fantastic article by Michael, B.D., Dunai, C., Needham, E.J. et al. which has been published in Nature Communications in December 2023. The researchers measured markers of…